AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
2/3/2009 1:19:16 PM
More...
|
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
11/26/2008 8:11:57 AM
More...
|
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
6/10/2008 8:44:53 AM
More...
|
Benezra Report in Nature Biotechnology Validates AngioGenex's Drug Development Platform by Demonstrating Tumor Suppression Through Id Protein Inhibition
1/8/2008 10:36:00 AM
More...
|
William Garland Joins AngioGenex's New Board of Directors
1/7/2008 10:47:03 AM
More...
|
AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
10/16/2007 8:42:47 AM
More...
|
AngioGenex European Listing Approved -- Company's Shares Now Trading on the Frankfurt Stock Exchange under Symbol 'TLE'
6/21/2007 11:48:51 AM
More...
|
AngioGenex Engages London & Pacific Healthcare to Assist in Attracting Investment Funding
5/4/2007 10:43:49 AM
More...
|
AngioGenex, BioCheck Collaboration Produces Novel Antibodies, Revenue and Progress toward a Cancer Diagnostic
5/3/2007 12:48:25 PM
More...
|
AngioGenex Listing Approved-Trading Under Symbol AGGX.OB
3/7/2007 2:13:37 PM
More...
|
|